Evidence map›Paper›PMID 27895580›Full record

ArticleFrontiers in pharmacology2016

Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma.

Andrea Russo, Rosario Caltabiano, Antonio Longo, Teresio Avitabile, Livio M Franco, Vincenza Bonfiglio, Lidia Puzzo, Michele Reibaldi

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Management of liver metastases from uveal melanoma.The British journal of surgery · 2025
    Review
  4. Role of miRNA in adult ocular tumorigenesis.Frontiers in molecular biosciences · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Liquid Biopsy in Uveal Melanoma: Are We There Yet?Ocular oncology and pathology · 2021
    Review
  14. Emerging roles of microRNAs and their implications in uveal melanoma.Cellular and molecular life sciences : CMLS · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. A Review of MicroRNA in Uveal Melanoma.OncoTargets and therapy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrea RussoDepartment of Ophthalmology, University of Catania Catania, Italy.
Rosario CaltabianoUnità di Anatomia Patologica, Department Gian Filippo Ingrassia, University of Catania Catania, Italy.
Antonio LongoDepartment of Ophthalmology, University of Catania Catania, Italy.
Teresio AvitabileDepartment of Ophthalmology, University of Catania Catania, Italy.
Livio M FrancoDepartment of Ophthalmology, University of Catania Catania, Italy.
Vincenza BonfiglioDepartment of Ophthalmology, University of Catania Catania, Italy.
Lidia PuzzoUnità di Anatomia Patologica, Department Gian Filippo Ingrassia, University of Catania Catania, Italy.
Michele ReibaldiDepartment of Ophthalmology, University of Catania Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

enucleationFFPEmicroRNAsserumuveal melanoma

Identifiers

PMID27895580
PMCPMC5108814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.